Observational studyBMC nephrology2026
Timing of treatment-switch to telitacicept in high-risk IgA nephropathy: an observational case series of two clinical scenarios.
Jiangyuan Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.